NEW ARTICLE ON TREATING CHOLERA WITH ONE OF THE APD'S | Akthelia

Antimicrobial resistance is an
increasingly serious threat to global public health
If antibiotics lose their eFFEctiveness, key medical
procedures could become too dangerous to perform.
An estimated 700.000 lives are lost yearly to
anti-microbial resistant infections.
The estimate for year 2050 is 10 million lives yearly.

NEW ARTICLE ON TREATING CHOLERA WITH ONE OF THE APD'S

June 15, 2017

Sarker P, Banik A, Stromberg R, Gudmundsson GH, Raqib R, Agerberth B. 2017. Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia. Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e02570-16. doi:10.1128/AAC.02570-16. Print 2017 Jul. PMID: 28438947

Eldri fréttir

Antimicrobial Peptides 2019, Gordon Research Conference

January 28, 2019
New substances are treating infections by activating the immune system

January 15, 2019
AKTHELIA SELECTED AS FINALIST FOR THE SCIENCE 2 STARTUP EVENT

February 27, 2018
MORGUNBLAÐIÐ, 20/10 2017

November 15, 2017
A CLINICAL TRIAL SHOWS THAT ONE OF AKTHELIA’S ACTIVES SPEEDS RECOVERY OF TUBERCULOSIS.

June 22, 2016
STEFAN JÖKULL SVEINSSON JOINS AKTHELIA’S BOARD

June 22, 2016
AKTHELIA APPLIES FOR PATENT FOR A NEW CLASS OF CHEMICALS

June 1, 2016
JÓN INGI BENEDIKTSSON JOINS AKTHELIA AS GENERAL MANAGER

June 22, 2016
MEMBERS OF AKTHELIA MANAGEMENT PLAY MAJOR ROLES AT ANTIBACTERIAL CONFERENCE.

October 10, 2009